Nervgen Pharma NGEN
NASDAQ NGEN
$1.52 -0.01 (-0.97%)
As of: Oct 21, 2026 · 1:04 PM EDT

Nervgen Pharma (NGEN) Other Working Capital Changes (2025 - 2026)

Updated

Nervgen Pharma's Other Working Capital Changes came in at $649,206 for the quarter ended Jun 30, 2026, compared with -$112,904 a year earlier.

Analysis

Nervgen Pharma (NGEN) Other Working Capital Changes (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Nervgen Pharma reported Other Working Capital Changes of -$1.2 million; for the year ended Dec 31, 2025, it was $423,151.

  • Going back by year, Other Working Capital Changes was -$163,416 in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,133.08 Bn 1,101.67 Bn 19.71 Bn
2 Johnson & Johnson 616.40 Bn 534.93 Bn 17.26 Bn
3 AbbVie 501.19 Bn 474.31 Bn 12.70 Bn
4 Merck 367.18 Bn 321.56 Bn 12.21 Bn
5 Novartis Ag 297.99 Bn 261.98 Bn 11.24 Bn
6 Astrazeneca 261.67 Bn 235.36 Bn 12.86 Bn
7 Amgen 235.57 Bn 190.97 Bn 7.24 Bn
8 Gilead Sciences 190.62 Bn 164.82 Bn 6.22 Bn
9 Pfizer 169.63 Bn 116.28 Bn 10.94 Bn
10 Nervgen Pharma 109.94 Mn 8.82 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -649,206.41
Mar 31, 2026 2.24 Mn
Jun 30, 2025 112,903.98
Mar 31, 2025 -510,160.28
API Access

Nervgen Pharma Other Working Capital Changes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-working-capital-changes&ticker=NGEN&period=max&api_key=YOUR_API_KEY